{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:44:57Z","timestamp":1764305097528,"version":"3.32.0"},"reference-count":124,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T00:00:00Z","timestamp":1243555200000},"content-version":"vor","delay-in-days":1428,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1080\/09595230500295725","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T18:24:55Z","timestamp":1129746295000},"page":"359-368","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature"],"prefix":"10.1111","volume":"24","author":[{"given":"JOACHIM D. K.","family":"UYS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAYMOND J. M.","family":"NIESINK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,29]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Club Health 2002 24 27 March 2002","key":"10.1080\/09595230500295725-BIB1|cit1","DOI":"10.1097\/00003727-200201000-00005"},{"key":"10.1080\/09595230500295725-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1592\/phco.21.20.1486.34472","article-title":"A comprehensive review of MDMA and GHB: two common club drugs","volume":"21","author":"Teter","year":"2001","journal-title":"Pharmacotherapy"},{"unstructured":"Johnston LD OMalley PM Bachman JG. Ecstasy use rises sharply among teens in 2000 1 February 2003 http:www.monitoringthefuture.org","key":"10.1080\/09595230500295725-BIB3|cit3"},{"volume-title":"The European Monitoring Centre for Drugs and Drug Addiction","year":"2002","author":"EMCDDA","key":"10.1080\/09595230500295725-BIB4|cit4"},{"key":"10.1080\/09595230500295725-BIB5|cit5","first-page":"21","volume-title":"Ecstasy: the complete guide","author":"Bravo","year":"2001"},{"key":"10.1080\/09595230500295725-BIB6|cit6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","article-title":"Psychological and cardiovascular effects and short-term sequelae of MDMA (ecstasy) in MDMA-naive healthy volunteers","volume":"19","author":"Vollenweider","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0278-5846(95)00231-6","article-title":"Subjective reports on the effects of the MDMA (ecstasy) experience in humans","volume":"19","author":"Cohen","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1080\/09595230500295725-BIB8|cit8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/02791072.1986.10472368","article-title":"MDMA. Nonmedical use and intoxication","volume":"18","author":"Siegel","year":"1986","journal-title":"J Psychoact Drugs"},{"key":"10.1080\/09595230500295725-BIB9|cit9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","article-title":"Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans","volume":"290","author":"Mas","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB10|cit10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","article-title":"Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens","volume":"18","author":"Nichols","year":"1986","journal-title":"J Psychoact Drugs"},{"key":"10.1080\/09595230500295725-BIB11|cit11","first-page":"369","article-title":"[Entactogenic drugs ecstasy (MDMA), eve (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?]","volume":"67","author":"Gouzoulis-Mayfrank","year":"1996","journal-title":"Nervenarzt"},{"key":"10.1080\/09595230500295725-BIB12|cit12","first-page":"508","article-title":"Nouvelles drogues synthetiques empathogenes [New synthesis empathogenic agents]","volume":"25","author":"Velea","year":"1999","journal-title":"Encephale"},{"volume-title":"GHB: the natural mood enhancer","year":"1997","author":"Dean","key":"10.1080\/09595230500295725-BIB13|cit13"},{"key":"10.1080\/09595230500295725-BIB14|cit14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00008480-200104000-00015","article-title":"The many faces of ecstasy","volume":"13","author":"Doyon","year":"2001","journal-title":"Curr Opin Pediatr"},{"key":"10.1080\/09595230500295725-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000050708","article-title":"Patterns of consumption","volume":"7","author":"Haasen","year":"2001","journal-title":"Eur Addict Res"},{"key":"10.1080\/09595230500295725-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000050709","article-title":"The use of drugs within the techno party scene in European metropolitan cities","volume":"7","author":"Tossmann","year":"2001","journal-title":"Eur Addict Res"},{"key":"10.1080\/09595230500295725-BIB17|cit17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(00)00215-5","article-title":"Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK","volume":"64","author":"Winstock","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/09595230500295725-BIB18|cit18","first-page":"627","article-title":"Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria","volume":"16","author":"Cottier","year":"2001","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1080\/09595230500295725-BIB19|cit19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/105504901750532111","article-title":"Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal","volume":"10","author":"Miotto","year":"2001","journal-title":"Am J Addict"},{"volume-title":"GHB: tussen extase en narcose","year":"2002","author":"Korf","key":"10.1080\/09595230500295725-BIB20|cit20"},{"unstructured":"Drug Abuse Warning Network http:www.samsha.govomsdawn.hm 6 April 2001","key":"10.1080\/09595230500295725-BIB21|cit21"},{"volume-title":"De combi-roes: gecombineerd gebruik van alcohol met cannabis, cocaine, XTC en amfetamine","year":"2000","author":"Nabben","key":"10.1080\/09595230500295725-BIB22|cit22"},{"key":"10.1080\/09595230500295725-BIB23|cit23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organization and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1080\/09595230500295725-BIB24|cit24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2003.08.002","article-title":"Multiple molecular and neuropharmacological effects of MDMA (Ecstasy)","volume":"74","author":"Simantov","year":"2004","journal-title":"Life Sci"},{"key":"10.1080\/09595230500295725-BIB25|cit25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(01)01163-3","article-title":"gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors","volume":"430","author":"Nava","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB26|cit26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(99)00063-4","article-title":"Prodynorphin and proenkephalin mRNAs are increased in rat brain after acute and chronic administration of gamma-hydroxybutyrate","volume":"262","author":"Schmidt-Mutter","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1080\/09595230500295725-BIB27|cit27","first-page":"29","volume-title":"Ecstasy: the complete guide","author":"Malberg","year":"2001"},{"key":"10.1080\/09595230500295725-BIB28|cit28","first-page":"167","article-title":"GHB: an important pharmacologic and clinical update","volume":"4","author":"Okun","year":"2001","journal-title":"J Pharm Pharm Sci"},{"key":"10.1080\/09595230500295725-BIB29|cit29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0149-7634(03)00031-9","article-title":"The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)","volume":"27","author":"Cole","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1080\/09595230500295725-BIB30|cit30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1080\/09595230500295725-BIB31|cit31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00213-004-1788-8","article-title":"Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function","volume":"173","author":"Colado","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/09595230500295725-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/0006-2952(70)90087-0","article-title":"Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain","volume":"19","author":"Roth","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1080\/09595230500295725-BIB33|cit33","first-page":"130","article-title":"Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain","volume":"207","author":"Doherty","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB34|cit34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0149-7634(94)90031-0","article-title":"Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and\/or a useful therapeutic agent","volume":"18","author":"Cash","year":"1994","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1080\/09595230500295725-BIB35|cit35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0028-3908(64)90074-7","article-title":"Sodium 4-Hydroxybutyrate","volume":"32","author":"Laborit","year":"1964","journal-title":"Int J Neuropharmacol"},{"key":"10.1080\/09595230500295725-BIB36|cit36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-6147(99)01341-3","article-title":"Gamma-hydroxybutyric acid: an endogenous neuro-modulator with abuse potential?","volume":"20","author":"Bernasconi","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1080\/09595230500295725-BIB37|cit37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.1997.tb03640.x","article-title":"Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence","volume":"92","author":"Galloway","year":"1997","journal-title":"Addiction"},{"key":"10.1080\/09595230500295725-BIB38|cit38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 2","key":"10.1080\/09595230500295725-BIB39|cit39","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0893-133X(98)00135-3","article-title":"Serotonin and hallucinogens","volume":"21","author":"Aghajanian","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB40|cit40","first-page":"1098","article-title":"(+)-N-methyl-1-(1,3-benzodioxol-5-yl)- 2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioural activity","volume":"255","author":"Oberlender","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB41|cit41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02246288","article-title":"Review of the pharmacology and clinical pharmacology of 3,4-methylene-dioxymethamphetamine (MDMA or Ecstasy)","volume":"119","author":"Green","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/09595230500295725-BIB42|cit42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF01285547","article-title":"Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its congeners","volume":"104","author":"Huether","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1080\/09595230500295725-BIB43|cit43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0361-9230(00)00419-6","article-title":"Neurochemical neutralization of amphetamine-type stimulants in rat brain by the indatraline analog (-)-HY038","volume":"53","author":"Partilla","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1080\/09595230500295725-BIB44|cit44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-2999(93)90819-4","article-title":"Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons","volume":"235","author":"Gu","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB45|cit45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0091-3057(93)90520-4","article-title":"Effect of acute monoamine depletion on 3,4- methylenedioxymethamphetamine-in-duced neurotoxicity","volume":"45","author":"Brodkin","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1080\/09595230500295725-BIB46|cit46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0006-2952(87)90729-5","article-title":"In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain","volume":"36","author":"Schmidt","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1080\/09595230500295725-BIB47|cit47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-2999(90)90555-K","article-title":"5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents","volume":"177","author":"Hekmatpanah","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB48|cit48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0301-0082(96)00027-5","article-title":"The effects of methylenedioxymethamphetamine (MDMA, Ecstasy) on monoaminergic neurotransmission in the central nervous system","volume":"49","author":"White","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1080\/09595230500295725-BIB49|cit49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1471-4159.1996.66010243.x","article-title":"Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions","volume":"66","author":"Gudelsky","year":"1996","journal-title":"J Neurochem"},{"key":"10.1080\/09595230500295725-BIB50|cit50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01273176","article-title":"MDMA induced dopamine release in vivo: role of endogenous serotonin","volume":"104","author":"Koch","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1080\/09595230500295725-BIB51|cit51","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00213-002-1104-4","article-title":"Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement","volume":"162","author":"Fletcher","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/09595230500295725-BIB52|cit52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/mol.53.4.649","article-title":"Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (Ecstasy) in serotonin transporter-deficient mice","volume":"53","author":"Bengel","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1080\/09595230500295725-BIB53|cit53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(88)90056-8","article-title":"Pharmacologic profile of MDMA (3,4-methylenedioxy-methamphetamine) at various brain recognition sites","volume":"149","author":"Battaglia","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB54|cit54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(86)90555-8","article-title":"The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain","volume":"128","author":"Stone","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB55|cit55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/npp.1994.26","article-title":"MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac)","volume":"10","author":"Leonardi","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB56|cit56","first-page":"456","article-title":"Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats","volume":"254","author":"Callaway","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB57|cit57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/npp.1993.22","article-title":"SerotoninlB receptor activation mimics behavioural effects of presynaptic serotonin release","volume":"8","author":"Rempel","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB58|cit58","first-page":"873","article-title":"Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxy-methamphetamine","volume":"245","author":"Nash","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB59|cit59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymetham-phetamine (MDMA, Ecstasy) are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB60|cit60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0893-133X(00)00126-3","article-title":"Psychological and physiological effects of MDMA (Ecstasy) after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans","volume":"23","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB61|cit61","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hup.348","article-title":"Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies","volume":"16","author":"Liechti","year":"2001","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1080\/09595230500295725-BIB62|cit62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0893-133X(00)00199-8","article-title":"Effects of MDMA (Ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin","volume":"24","author":"Liechti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB63|cit63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","article-title":"The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (Ecstasy) in healthy volunteers","volume":"14","author":"Liechti","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1080\/09595230500295725-BIB64|cit64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0031-6989(73)80025-6","article-title":"Stimulation of serotonin synthesis by anesthetic and non-anesthetic doses of gamma-hydroxybutyrate","volume":"5","author":"Spano","year":"1973","journal-title":"Pharmacol Res Commun"},{"key":"10.1080\/09595230500295725-BIB65|cit65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(78)90075-4","article-title":"Effects of baclofen and gamma-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism","volume":"49","author":"Waldmeier","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB66|cit66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01250046","article-title":"Effect of gammahydroxybutyric acid on serotonin synthesis, concentration and metabolism in the developing rat brain","volume":"57","author":"Hedner","year":"1983","journal-title":"J Neural Transm"},{"key":"10.1080\/09595230500295725-BIB67|cit67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00973292","article-title":"Effect of low doses of gamma-hydroxybutyric acid on serotonin, noradrenaline, and dopamine concentrations in rat brain areas","volume":"13","author":"Miguez","year":"1988","journal-title":"Neurochem Res"},{"key":"10.1080\/09595230500295725-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0024-3205(01)01526-0","article-title":"Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain","volume":"70","author":"Gobaille","year":"2002","journal-title":"Life Sci"},{"key":"10.1080\/09595230500295725-BIB69|cit69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF02246266","article-title":"Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts","volume":"122","author":"Malison","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/09595230500295725-BIB70|cit70","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"10.1080\/09595230500295725-BIB71|cit71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v10.i3-4.30","article-title":"The frontal cortex -basal ganglia system in primates","volume":"10","author":"Wise","year":"1996","journal-title":"Crit Rev Neurobiol"},{"key":"10.1080\/09595230500295725-BIB72|cit72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci"},{"key":"10.1080\/09595230500295725-BIB73|cit73","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/09595230500295725-BIB74|cit74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-3057(97)00424-3","article-title":"CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences","volume":"59","author":"Bilsky","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1080\/09595230500295725-BIB75|cit75","first-page":"1063","article-title":"Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra","volume":"273","author":"Yamamoto","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB76|cit76","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0893-133X(01)00240-8","article-title":"Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behaviour","volume":"25","author":"Sasaki-Adams","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB77|cit77","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.2002.tb04182.x","article-title":"Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study","volume":"965","author":"Gough","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1080\/09595230500295725-BIB78|cit78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0893-133X(97)00195-4","article-title":"MDMA elicits behavioural and neurochemical sensitization in rats","volume":"18","author":"Kalivas","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/09595230500295725-BIB79|cit79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0091-3057(98)00103-8","article-title":"Effect of 3,4-methylenediox-ymethamphetamine (MDMA) on hippocampal dopamine and serotonin","volume":"61","author":"Shankaran","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1080\/09595230500295725-BIB80|cit80","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(91)90137-Q","article-title":"Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on mono-amines in rat caudate","volume":"39","author":"Gough","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1080\/09595230500295725-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1471-4159.1994.62041382.x","article-title":"Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethampheta-mine","volume":"62","author":"Schmidt","year":"1994","journal-title":"J Neurochem"},{"key":"10.1080\/09595230500295725-BIB82|cit82","first-page":"820","article-title":"Microdialysis studies on 3,4-methyle-nedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors","volume":"259","author":"Nash","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB83|cit83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(91)91640-M","article-title":"MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system","volume":"539","author":"Pan","year":"1991","journal-title":"Brain Res"},{"key":"10.1080\/09595230500295725-BIB84|cit84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(86)90615-1","article-title":"Effects of the enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H] dopamine release from superfused rat brain slices","volume":"132","author":"Johnson","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB85|cit85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(88)90564-X","article-title":"The acute effects of methyle-nedioxymethamphetamine on dopamine release in the awake-behaving rat","volume":"148","author":"Yamamoto","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB86|cit86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0306-4522(94)90313-1","article-title":"Methylenedioxymetham-phetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo","volume":"62","author":"White","year":"1994","journal-title":"Neuroscience"},{"key":"10.1080\/09595230500295725-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0024-3205(89)90418-9","article-title":"Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats","volume":"45","author":"Porrino","year":"1989","journal-title":"Life Sci"},{"key":"10.1080\/09595230500295725-BIB88|cit88","first-page":"177","volume-title":"Amphetamine and its analogs: psychopharmacology, toxicology, and abuse","author":"Geyer","year":"1994"},{"key":"10.1080\/09595230500295725-BIB89|cit89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s002130050664","article-title":"Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) but not by fenfluramine","volume":"138","author":"Dafters","year":"1998","journal-title":"Psycho-pharmacology (Berl)"},{"key":"10.1080\/09595230500295725-BIB90|cit90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(91)90288-D","article-title":"Effects of 3,4-methylenedioxymethamphetamine on auto-nomic thermoregulatory responses of the rat","volume":"38","author":"Gordon","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1080\/09595230500295725-BIB91|cit91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0091-3057(88)90001-9","article-title":"Stimulus properties of l-(3,4-methylenedioxyphenyl)- 2-aminopropane (MDA) analogs","volume":"29","author":"Glennon","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1080\/09595230500295725-BIB92|cit92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02245958","article-title":"Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methyle-nedioxy analogues of amphetamine","volume":"118","author":"Hegadoren","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1080\/09595230500295725-BIB93|cit93","first-page":"345","article-title":"Psychostimulant properties of MDMA","volume":"95","author":"Gold","year":"1989","journal-title":"NIDA Res Monogr"},{"key":"10.1080\/09595230500295725-BIB94|cit94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/16066350290001704","article-title":"Behavioural psychopharmacology of MDMA and MDMA-like drugs: a review of human and animal studies","volume":"10","author":"Martinez-Price","year":"2002","journal-title":"Addict Res Theory"},{"key":"10.1080\/09595230500295725-BIB95|cit95","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3565(24)29607-5","article-title":"3,4-Methylenedioxy-methamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions","volume":"297","author":"Bankson","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB96|cit96","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(00)00086-9","article-title":"Acute psychological and physiological effects of MDMA (Ecstasy) after haloperidol pretreatment in healthy humans","volume":"10","author":"Liechti","year":"2000","journal-title":"Eur Neuropsychopharma-col"},{"key":"10.1080\/09595230500295725-BIB97|cit97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4324\/9780203300992_chapter_6","volume-title":"Gamma-hydroxybutyrate","author":"Howard","year":"2002"},{"key":"10.1080\/09595230500295725-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/BF01271186","article-title":"The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate-and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice","volume":"103","author":"Nissbrandt","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1080\/09595230500295725-BIB99|cit99","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(02)01502-9","article-title":"Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid","volume":"441","author":"Carai","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB100|cit100","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1073\/pnas.92.26.12304","article-title":"Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the shell as compared with the core of the rat nucleus accumbens","volume":"92","author":"Pontieri","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/09595230500295725-BIB101|cit101","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron"},{"key":"10.1080\/09595230500295725-BIB102|cit102","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/19208","article-title":"Drug addiction: bad habits add up","volume":"398","author":"Robbins","year":"1999","journal-title":"Nature"},{"key":"10.1080\/09595230500295725-BIB103|cit103","first-page":"1010","article-title":"Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine","volume":"248","author":"Ritz","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB104|cit104","first-page":"1597","article-title":"Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: a microdialysis study in freely moving rats","volume":"271","author":"Chen","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1046\/j.1471-4159.1994.63051701.x","article-title":"Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships","volume":"63","author":"Chen","year":"1994","journal-title":"J Neurochem"},{"key":"10.1080\/09595230500295725-BIB106|cit106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0006-8993(94)91570-9","article-title":"Regional extracellular noradrenaline responses to amphetamine and cocaine and effects of clonidine pretreatment","volume":"654","author":"Florin","year":"1994","journal-title":"Brain Res"},{"key":"10.1080\/09595230500295725-BIB107|cit107","first-page":"231","article-title":"Effects of reserpine on extracellular caudate dopamine and hippocampus noradrenaline responses to amphetamine and cocaine: mechanistic and behavioural considerations","volume":"274","author":"Florin","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB108|cit108","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0006-3223(99)00245-0","article-title":"Genetic approaches to studying noradrenaline function: knockout of the mouse noradrenaline transporter gene","volume":"46","author":"Wang","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1080\/09595230500295725-BIB109|cit109","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1016\/S0021-9258(17)33961-3","article-title":"Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-noradrenaline transporters","volume":"269","author":"Giros","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1080\/09595230500295725-BIB110|cit110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/350350a0","article-title":"Expression cloning of a cocaine- and antidepressant-sensitive human noradrenalinee transporter","volume":"350","author":"Pacholczyk","year":"1991","journal-title":"Nature"},{"key":"10.1080\/09595230500295725-BIB111|cit111","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-2396(19990915)33:4<268::AID-SYN3>3.0.CO;2-W","article-title":"GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans","volume":"33","author":"Villemagne","year":"1999","journal-title":"Synapse"},{"key":"10.1080\/09595230500295725-BIB112|cit112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release noradrenaline more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1080\/09595230500295725-BIB113|cit113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(90)94150-V","article-title":"Effects of methylenedioxymetham-phetamine on the release of monoamines from rat brain slices","volume":"191","author":"Fitzgerald","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB114|cit114","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.bjp.0702875","article-title":"Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens","volume":"128","author":"Lavelle","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1080\/09595230500295725-BIB115|cit115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-133-12-200012190-00012","article-title":"Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial","volume":"133","author":"Lester","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1080\/09595230500295725-BIB116|cit116","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/0006-2952(87)90594-6","article-title":"Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain","volume":"36","author":"Steele","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1080\/09595230500295725-BIB117|cit117","first-page":"301","article-title":"Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo","volume":"210","author":"Griffiths","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/09595230500295725-BIB118|cit118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-3223(95)00110-7","article-title":"Subjective responses to d-ampheta-mine alone and after pimozide pretreatment in normal, healthy volunteers","volume":"39","author":"Brauer","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1080\/09595230500295725-BIB119|cit119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00008877-199406000-00005","article-title":"Reinforcing and subjective effects of methyl-phenidate in humans","volume":"5","author":"Chait","year":"1994","journal-title":"Behav Pharmacol"},{"key":"10.1080\/09595230500295725-BIB120|cit120","first-page":"1633","article-title":"[Effect of gamma-butyrolactone on the cerebral content of monamine]","volume":"42","author":"Vargiu","year":"1966","journal-title":"Boll Soc Ital Biol Sper"},{"key":"10.1080\/09595230500295725-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/0024-3205(66)90261-X","article-title":"Selective increase of brain dopamine induced by gamma hydroxybutyrate","volume":"5","author":"Gessa","year":"1966","journal-title":"Life Sci"},{"key":"10.1080\/09595230500295725-BIB122|cit122","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-4159.1991.tb02012.x","article-title":"Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study","volume":"56","author":"Hechler","year":"1991","journal-title":"J Neurochem"},{"key":"10.1080\/09595230500295725-BIB123|cit123","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/0006-2952(90)90581-5","article-title":"Pyretic action of low doses of gamma-hydroxybutyrate in rats","volume":"40","author":"Kaufman","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1080\/09595230500295725-BIB124|cit124","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.300.1.236","article-title":"3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics","volume":"300","author":"Hernandez-Lopez","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F09595230500295725","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F09595230500295725","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/09595230500295725\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T02:26:02Z","timestamp":1736043962000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/09595230500295725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"URL":"https:\/\/doi.org\/10.1080\/09595230500295725","archive":["Portico"],"relation":{},"ISSN":["0959-5236"],"issn-type":[{"type":"print","value":"0959-5236"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}